HeartHab, Can a Patient-tailored Application Support Coronary Artery Disease Patients During Rehabilitation?

NCT02668757 | Completed

• 1 other identifier: HeartHab-001
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The HeartHab study is a pilot trial in which coronary artery disease patients (n = 15-30) are given the HeartHab application. The HeartHab application is a smarthphone based mobile application that serves as a secondary prevention tool, to support cardiac patients after their phase II cardiac rehabilitation program. During study period (4-6 weeks), participating patients will be asked to use the application. HeartHab includes a module devoted to therapy compliance, one to exercise training prescription and one to risk factor control. HeartHab aims to motivate the patient to improve his/her self-management skills and hence decrease cardiovascular morbidity (and mortality). Motivational aspects and usability data will be collected during study period by means of app logs and/or questionnaires/interviews.

Conditions

Coronary Artery Disease

Outcome Measures

Primary Outcomes (1)

• Impact on motivation

  By means of a questionnaire and an interview, questions are asked about participants' motivation for a tour

  week 6

Secondary Outcomes (1)

• Usability of the HeartHab application

  week 6

Study Arms (1)

HeartHab application arm

OTHER

Patients in the HeartHab application arm will receive the mobile application during study period.

Behavioral: HeartHab application intervention

Interventions

HeartHab application intervention BEHAVIORAL

The intervention patients will use the HeartHab application on a smartphone. During the study, the patients will use the HeartHab application for 4-6 weeks.

HeartHab application arm

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with coronary artery disease for which they received a percutaneous coronary intervention, coronary artery bypass grafting or drugs only.
• Patients that have completed the standard cardiac rehabilitation program
• Patients who have access to a computer and a WiFi internet connection
• Patients that are able to go to the rehabilitation centre ReGo of Jessa Hospital
• Patients who signed the informed consent document

You may not qualify if:

• Patients with a history of VF, sustained VT and/or supraventricular tachycardia during the last 6 months before enrollment.
• Patients who due to cognitive, neurological and/or musculoskeletal constraints are unable to ride a bicycle.
• Patients with a pacemaker or defibrillator.
• Non-Dutch speaking patients
• Patients who simultaneously participate in another study

Sponsors & Collaborators

• Hasselt University: lead

Study Sites (1)

Jessa Ziekenhuis

Hasselt, Belgium

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary Disease; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases

Study Officials

• Paul Dendale, Prof. dr.

  paul.dendale@jessazh.be

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: prof. dr.

Study Record Dates

• First Submitted: January 27, 2016
• First Posted: January 29, 2016
• Study Start: March 1, 2016
• Primary Completion: December 31, 2017
• Study Completion: December 31, 2017
• Last Updated: February 28, 2018

Record last verified: 2018-02

Data Sharing

• IPD Sharing: Will not share

Locations

BE (1)